TerminatedNCT01928043
Adjunctive Curcumin for Symptomatic Adolescents With Bipolarity: Brain and Body Considerations
Medication studyAges 13–19Canada
Understand this study
Who could participate?
This study is for people with bipolarity. Listed age limits: 13 years to 19 years. Other eligibility criteria apply.
- Listed locations
- TorontoSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateSeptember 2013
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 7
- Sponsor
- Sunnybrook Health Sciences Centre
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Canada
- Age range
- From 13 Years to 19 Years
- Official registry ID
- NCT01928043
- Official title
Show the full official title
Adjunctive Curcumin for Symptomatic Adolescents With Bipolar Disorder: Brain and Body Considerations
Recruitment & locations
TerminatedToronto
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Sunnybrook Health Sciences Centre.
Does this study involve medication?
Yes. The study involves medication, including Curcumin.
Who can participate?
This study is for people with bipolarity. Listed age limits: 13 years to 19 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
